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Abstract
Background:  The multisubunit (α 1S,α 2-δ , β 1a and γ 1) skeletal muscle dihydropyridine receptor
(DHPR) transduces membrane depolarization into release of Ca2+ from the sarcoplasmic reticulum
(SR) and also acts as an L-type Ca2+ channel. To more fully investigate the function of the γ 1 subunit
in these two processes, we produced mice lacking this subunit by gene targeting.
Results:  Mice lacking the DHPR γ 1 subunit (γ 1 null) survive to adulthood, are fertile and have no
obvious gross phenotypic abnormalities. The γ 1 subunit is expressed at approximately half the
normal level in heterozygous mice (γ 1 het). The density of the L-type Ca2+ current in γ 1 null and
γ 1 het myotubes was higher than in controls. Inactivation of the Ca2+ current produced by a long
depolarization was slower and incomplete in γ 1 null and γ 1 het myotubes, and was shifted to a more
positive potential than in controls. However, the half-activation potential of intramembrane charge
movements was not shifted, and the maximum density of the total charge was unchanged. Also, no
shift was observed in the voltage-dependence of Ca2+ transients. γ 1 null and γ 1 het myotubes had
the same peak Ca2+ amplitude vs. voltage relationship as control myotubes.
Conclusions:  The L-type Ca2+ channel function, but not the SR Ca2+ release triggering function
of the skeletal muscle dihydropyridine receptor, is modulated by the γ 1 subunit.
Background
In skeletal muscle, the dihydropyridine receptor (DHPR)
consists of α 1S, α 2-δ , β 1a and γ 1 subunits [1]. This complex
is responsible for the L-type Ca2+ current and serves as
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the voltage sensor for excitation-contraction (EC) cou-
pling. In the latter process, the movement of electrical
charges in the α 1S subunit promotes a conformational
change that opens the ryanodine receptor type-1 (RyR1)
in the sarcoplasmic reticulum membrane (SR) leading to
an increase in cytosolic Ca2+ [2,3]. The functional inter-
actions between the DHPR subunits necessary for open-
ing the Ca2+ channel are only partially known. Further,
the interactions between DHPR subunits and RyR1 also
are incompletely understood. The α 1 subunit is a large
protein that contains the basic functional elements of the
L-type Ca2+ channel, including the Ca2+ selectivity, volt-
age-dependent gating, and sensitivity to dihydropyrid-
ines. The cytoplasmic loop between repeats II and III of
the α 1S subunit interacts closely with RyR1 and is an im-
portant determinant of skeletal type EC coupling [4,5]. A
region in the cytoplasmic loop between repeats I and II
of the α 1 subunit, referred to as the AID [6], binds tightly
with a 30 amino acid region on the β 1 subunit, referred to
as the BID [7]. β  subunits are ∼  55 to 65 kDa proteins es-
sential for channel assembly and/or membrane target-
ing, as well as for modulation of channel kinetics [8]. The
α 2-δ  subunit is a highly glycosylated ∼  175 kDa protein
formed by two disulfide-linked peptides encoded by the
same gene. Transmembrane topology and functional
analyses suggest the α 2-δ  subunit is composed of a single
transmembrane domain and a short cytoplasmic tail of
only five residues [9,10]. Given this topology, the α 2-δ
subunit is most likely to interact with the α 1 and/or the γ 1
subunits. The γ 1 subunit is a ∼  32 kDa skeletal muscle-
specific protein with four presumptive transmembrane
domains [11,12,13]. The transmembrane topology of the
γ 1 subunit and the critical binding domains are unknown
at this time.
EC coupling is initiated by voltage-dependent charge
movements in the S4 segments of the DHPR α 1S subunit,
whose expression is dependent on the presence of the β 1a
subunit [14]. The C-terminus of the β 1a subunit has also
been shown to be important in EC coupling, presumably
by interaction with RyR1 [15]. The role of the α 2-δ  subu-
nit on skeletal EC coupling is unknown, but in heterolo-
gous expression systems it has been demonstrated to
increase the amount of charge movement [16]. The role
of the γ 1 subunit in Ca2+ channel function is of particular
interest given the discovery of a second γ  subunit, γ 2 or
stargazin, which is expressed in neurons and is respon-
sible for the stargazer mutation in mice [17]. Subse-
quently, several other γ  subunit genes have been
identified and shown to be expressed in brain and pe-
ripheral tissues [18,19]. In the present study we exam-
ined the role of the γ 1 subunit in L-type Ca2+ current and
EC coupling in skeletal myotubes. Absence of the γ 1 sub-
unit slows inactivation and produces a depolarizing shift
in the Ca2+ current inactivation vs. voltage curve, in
agreement with results from an independently produced
γ 1 knockout mouse [20]. However, absence of γ 1 does not
affect the voltage dependence or the magnitude of charge
movements and Ca2+ transients. Overall, the γ 1 subunit
appears to promote inhibition of the Ca2+ channel func-
tion of the skeletal DHPR. While this subunit is clearly
non-essential for activation of the L-type Ca2+ channel
and for triggering skeletal-type EC coupling, γ 1 appears
to specifically modulate the Ca2+ channel function of the
skeletal DHPR.
Results and Discussion
Inactivation of the DHPR γ 1 subunit by gene targeting
Gene targeting was used to replace the entire coding re-
gion of the γ 1 gene with the neo gene, as described in Ma-
terials and Methods (Fig. 1). Targeted ES cell clones were
injected into C57Bl/6J blastocysts and chimeras ob-
tained. After additional breeding, a line containing the γ 1
targeted allele was obtained. Fig. 1A shows Southern
blots from DNA of control (+/+), γ 1 het (+/-) and γ 1 null
(-/-) mice, after digestion with EcoRI and hybridization
to probe 1. The γ 1 het and γ 1 null mice show the predicted
12.5 kb restriction fragment indicative of the targeted al-
lele (Fig. 1B). Similarly for the Southern blot of DNA di-
gested with HindIII and hybridized to probe 2, the γ 1 het
and γ 1 null mice show the predicted 3.5 kb restriction
fragment indicative of the targeted allele (Fig. 1C). The γ 1
het and γ 1 null mice have no visible abnormalities and are
fertile. Western blots showing the expression of the
DHPR subunits are shown in Fig 1D. The amount of the
γ 1 subunit present in control, γ 1 het and γ 1 null samples as
a function of total membrane protein was determined in
two independent membrane preparations. These data
indicate that the amount of γ 1 expression in membranes
from γ 1 null muscle was not detectable above background
(no primary antibody) as expected from the fact that the
entire gene was deleted. In membranes isolated from the
γ 1 het mice, the level of expression of the γ 1 subunit was
64% of control values for each of the two independent
determinations, consistent with what might be expected
from the loss of one allele. Whether there is compensa-
tion by increased expression of other γ  subunits such as
the γ 6 and γ 7 subunits, which were shown recently to be
present in skeletal muscle by RT-PCR [19], or alteration
of the amount of the other subunits remains to be deter-
mined in the future.
Increase in Ca2+ current density and decrease in inactiva-
tion in γ 1 null and γ 1 het myotubes
We examined the impact of the γ 1 null mutation on
DHPR properties using electrophysiological techniques
in primary cultures of skeletal myotubes derived from
mouse embryos. Fig. 2A shows whole-cell Ca2+ currents
in control, γ 1 het and γ 1 null myotubes in response to
500-ms depolarizing voltage steps from a holding poten-BMC Physiology (2001) 1:8 http://www.biomedcentral.com/1472-6793/1/8
Figure 1
Inactivation of the γ 1 subunit by gene targeting. A) i. The normal γ 1 gene, which contains 4 exons (represented by black
boxes). ii. The targeting vector contains a fragment with 4.4 kb of homology to a region 5' of exon 1 and a 2.6 kb fragment with
homology to a region 3' of exon 4 (thick horizontal lines). These fragments are separated by the neo gene, which is used to
select the ES cells in culture. iii. The modified γ 1 locus. When recombination occurs in the regions indicated by the X's, all 4
exons of the γ 1 gene are replaced by the neo cassette. B, C) Southern blots of DNA, either digested with EcoRI and hybridized
to probe 1 (B), or DNA digested with HindIII and hybridized to probe 2 (C), from control (+/+), γ 1 het (+/-) and γ 1 null (-/-)
mice. These data show the predicted size bands for the wild type and targeted alleles. D) Western blots for each of the four
skeletal DHPR subunits from control (+/+), γ 1 het (+/-) and γ 1 null (-/-) mice. The γ 1 subunit is absent from the γ 1 null mice and
at approximately half the normal level in the γ 1 het mice.
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tial of -40 mV. Current traces for only three voltage steps
are shown for clarity. All three cell types displayed the
slow, high-voltage activated L-type Ca2+ current typical
of skeletal myotubes. When the holding potential was -
80 mV, we also observed a T-type Ca2+ current, which
was seen in approximately half of the cells tested (data
not shown). Ca2+ conductance vs. voltage curves were
computed in Fig. 2B for the three cell types. The sigmoi-
dal lines correspond to a Boltzmann fit to the population
mean while parameters fitted to each cell are shown in
Table 1. These data show that the maximum conduct-
ance, Gmax, for both the γ 1 het and γ 1 null cells are signif-
icantly larger (p<0.05) than the values for control cells.
However, the half-activation potential (V1/2) and the
steepness of the curve (factor k) were not significantly
different (see Table 1). Thus, full or partial elimination of
the γ 1 subunit produced a significant increase in the Ca2+
current density without a change in the voltage-depend-
ence of the Ca2+ conductance.
At intermediate potentials such as +30 mV (Fig. 2A), the
Ca2+ current of γ 1 het and γ 1 null cells inactivated more
slowly than that of control cells. To examine changes in
inactivation, we used the paired-pulse protocol shown in
Fig. 3A, which measured the Ca2+ current not inactivated
by the pre-pulse. It has been shown that inactivation of
Figure 2
L-type Ca2+ conductance in γ 1 knockout myotubes. A) Whole-cell L-type Ca2+ current when control (+/+), γ 1 het (+/-
), or γ 1 null (-/-) myotubes are depolarized to either -10 mV, +30 mV or +60 mV from a holding potential of -40 mV. The pulse
duration was 500 ms. The cell capacitance was 262 pF, 221 pF, and 286 pF, for the control, γ 1 het and γ 1 null cells, respectively.
B) Voltage dependence of the Ca2+ conductance for 8 control, 8 γ 1 het and 12 γ 1 null cells. The curves correspond to a Boltz-
mann fit of the population mean with the following parameters. Gmax = 132 pS/pF, V1/2 = 13.4 mV and k = 5.3 mV for control
cells; Gmax = 160 pS/pF, V1/2 = 13 mV and k = 5.8 mV for γ 1 het cells; and Gmax = 167 pS/pF, V1/2 = 9.9 mV and k = 4.6 mV for
γ 1 null cells.BMC Physiology (2001) 1:8 http://www.biomedcentral.com/1472-6793/1/8
skeletal L-type Ca2+ channels approaches steady-state
extremely slowly, on the time scale of tens of seconds
[21]. However, for comparative purposes and to be
consistent with previous measurements in Ca2+ chan-
nels lacking γ 1 [20,22], we chose a much shorter proto-
col. Cells were held at -80 mV, then stepped to a series of
depolarizing (pre-pulse) voltages for 2.5 s to promote in-
activation, then stepped to -50 mV for 100 ms to close
non-inactivated channels. The non-inactivated Ca2+ cur-
rent was measured during a 200-ms test pulse to +20
mV. In control cells, there was almost complete inactiva-
tion of the Ca2+ current when the pre-pulse potential was
in the positive range. This can be seen by comparing the
amplitude of the Ca2+ current during the test pulse in
traces 1, 2, and 3, corresponding to pre-pulse potentials
to -70 mV, +30 mV, and +60 mV, respectively. In con-
Figure 3
Slow inactivation of the Ca2+ current in γ 1 knockout myotubes. A) Diagram to scale of the two-pulse protocol used
to inactivate the L-type Ca2+ current at each of 15 potentials and then the test potential (+20 mV) to measure the remaining
non-inactivated current. Ca2+ currents during the pre-pulse and test-pulse phases of the protocol are shown for a pre-pulse
depolarization to -70 mV (trace 1), +30 mV (trace 2) and +60 mV (trace 3) in a control, a γ 1 het, and a γ 1 null myotube. The
cell capacitance was 317 pF for the control, 175 pF for the γ 1 het and 348 pF for the γ 1 null cell. B) The maximum Ca2+ current
during the test pulse is plotted as a function of the pre-pulse potential for 6 control, 8 γ 1 het and 8 γ 1 null cells. C) The non-
activating component was subtracted and the curves were normalized to show the voltage-dependence of the inactivating
component. I is the maximum test current, Imin is the test current at +50 mV and Imax is the test current at -70 mV. The
curves correspond to a Boltzmann fit of the population mean with the following parameters. [(I-Imin)/Imax]max = 1, V1/2 = -3.8
mV and k = 8.4 mV for control cells. [(I-Imin)/Imax]max = 1, V1/2 = +15.6 mV and k = 8.1 mV for γ 1 het cells. [(I-Imin)/Imax]max
= 1, V1/2 = +9.7 mV and k = 7.9 mV for γ 1 null cells.
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trast, γ 1 het and γ 1 null cells showed less inactivation dur-
ing the pre-pulse, and thus a significantly larger Ca2+
current during the test pulse. Furthermore, pre-pulse
potentials larger than +30 mV did not promote addition-
al inactivation, which can be seen by comparing traces 2
and 3 in the γ 1 het and γ 1 null cells. Fig. 3B shows the
maximum Ca2+ current during the test pulse plotted as a
function of the pre-pulse potential. In control cells, inac-
tivation was complete when the pre-pulse potential was
above +30 mV (-6.9 ± 0.8 pA/pF at -70 mV vs. -0.2 ± 0.2
pA/pF at +70 mV, n = 6 cells). In γ 1 null cells, inactiva-
tion reached a plateau when the pre-pulse potential was
more positive than +20 mV (-8.5 ± 0.9 pA/pF at -70 mV
vs. -3.2 ± 0.7 pA/pF at +70 mV, n = 8 cells). Incomplete
inactivation was also seen in γ 1 het cells, although this
was less pronounced than in γ 1 null cells. Since the pre-
pulse was not sufficiently long for inactivation to reach
steady-state, we are not certain whether the observed in-
complete inactivation reflects a component of the γ 1 null
Ca2+ current that inactivates extremely slowly or a "tru-
ly" non-inactivating component. To compare the volt-
age-dependence of the inactivation produced by the 2.5-
second pre-pulse, the Ca2+ current during the test pulse
was normalized and fit to the Boltzmann equation (Fig.
3C). The curves for γ 1 het and γ 1 null cells showed a sig-
nificant (p<0.05) shift to more positive potentials com-
pared to control cells. The same conclusion was reached
by comparing the Boltzmann parameters of individual
cells in Table 1. Since control cells had a more negative
half inactivation potential, the higher Ca2+ conductance
of γ 1 het and γ 1 null cells reported in Fig. 2 could be ex-
plained by a larger steady-state inactivation of the con-
trol Ca2+ current at the -40 mV holding potential. To
determine if this was the case, we measured the Ca2+
conductance during the pre-pulse for the same cells ana-
lyzed in Fig 3B,C. The pre-pulse was delivered from a
holding potential of -80 mV, and therefore the pre-pulse
current should be less contaminated by steady-state in-
activation. Gmax at the peak of the Ca2+ current during
the pre-pulse was 146 ± 12 pS/pF for controls, 172 ± 18
pS/pF γ 1 het and 186 ± 13 pS/pF for γ 1 null cells with t-
test statistical significance for controls vs. γ 1 null cells of
p = 0.034 and for controls vs. γ 1 het cells of p = 0.064.
Thus the higher Ca2+ conductance of γ 1 het and γ 1 null
Table 1: Boltzmann parameters of Ca2+ conductance, charge movements and Ca2+ transients of control, γ 1 het and γ 1 null myotubes.
CELL TYPE G-V Q-V
Gmax (pS/pF) V1/2 (mV) k (mV) Qmax (fC/pF) V1/2 (mV) k (mV)
Control, +/+ 131 ± 6.2 14.7 ± 2.1 4.2 ± 0.4 5.3 ± 0.4 11.4 ± 2.5 15.4 ± 1.1
(n) (8) (8)
γ 1 het, +/- 161 ± 11.5a 14.3 ± 2.8 5 ± 0.8 5.3 ± 0.3 14.4 ± 0.6 14.7 ± 2.0
(n) (8) (4)
γ 1 null, -/- 170 ± 9.6b 10.9 ± 0.9 4.5 ± 0.4 5.3 ± 0.9 17.8 ± 1.9 15.8 ± 2.2
(n) (12) (8)
∆ F/Fo-V Inactivation
∆ F/Fo(max) V1/2 (mV) k (mV) V1/2 (mV) k (mV)
Control, +/+ 3.9 ± 0.3 4.6 ± 1.2 10.2 ± 1.3 -4.6 ± 3.6 7.3 ± 0.2
(n) (6) (6)
γ 1 het, +/- 3.3 ± 0.5 8.2 ± 3.0 10.1 ± 2.0 8.1 ± 2.3c 8.0 ± 0.6
(n) (4) (8)
γ 1 null, -/- 3.7 ± 0.4 7.3 ± 1.6 9.0 ± 1.1 8.9 ± 0.8d 8.1 ± 0.8
(n) (6) (8)
Entries (mean ± SEM) correspond to Boltzmann parameters fitted to each cell (number of cells n, in parenthesis). The only statistically significant 
differences (p<0.05) were for either γ 1 het or γ 1 null cells compared to control cells as indicated. The t-test p values were 0.004, 0.009, 0.011, 0.009 
for a-d, respectively.BMC Physiology (2001) 1:8 http://www.biomedcentral.com/1472-6793/1/8
cells persisted at the more negative holding potential.
These Ca2+ conductances were approximately 10% high-
er than those at the -40 mV holding potential reported in
Table 1. The additional current could have been contrib-
uted by T-type Ca2+ channels (not shown), which are
available at the -80 mV holding potential but are inacti-
vated at the more positive holding potential. Also, since
the T-type Ca2+ current density was highly variable (see
above), this could explain the higher p values compared
to those reported in Table 1. In summary, decreasing the
amount of the γ 1 subunit protein or eliminating it com-
pletely resulted in myotubes with a higher Ca2+ current
density, a similar voltage-dependence of activation, and
a reduced rate of inactivation. These results, with the ex-
ception of the change in Ca2+ current density, are in re-
markable agreement with those obtained when L-type
Ca2+ channel subunits are coexpressed without the γ 1
subunit in heterologous cells (see below). They also are
similar to results obtained elsewhere in γ 1 null myotubes
using a 5-second pre-pulse [20]. Furthermore, the in-
complete inactivation of the γ 1 null Ca2+ current resem-
bles that observed in ts A201 cells expressing DHPRs
specifically lacking γ 1 and using a 3-second inactivation
protocol [22].
The effect of the γ 1 subunit on Ca2+ current kinetics has
been somewhat confusing until now, because it has not
been possible to examine its role using homologous sub-
units and a homologous expression system. In amphibi-
an oocytes, γ 1 was assayed in a complex with α 1C, β 1a and
α 2-δ  [23,24]. These investigators found γ 1 produced a
slight decrease in Ca2+ current density, no change in ac-
tivation kinetics and a positive shift in the peak Ca2+ cur-
rent vs. voltage curve. In HEK293 cells using the same
subunit composition, the γ 1 subunit did not alter the ki-
netics or density of Ca2+ currents [25]. However, in both
oocytes and HEK293 cells, the γ 1 subunit increased the
rate of Ca2+ channel inactivation and produced a large
hyperpolarizing shift in steady-state inactivation
[23,25,26]. The results obtained here in skeletal muscle
demonstrate that absence of the γ 1 subunit increases
Ca2+ current density, decreases the inactivation rate, and
shifts the voltage-dependence of inactivation in the de-
polarizing direction. Freise et al. [20] showed that the in-
crease in Ca2+ current was not a result of changes in
single channel conductance and suggested the effects
were due to changes in channel open probability. How-
ever, this remains to be tested directly. Expression of the
γ 2 subunit in BHK cells expressing α 1A, α 2-δ  and β 1a also
shifts the voltage-dependence of inactivation ∼  7 mV in
the hyperpolarizing direction [17]. In summary, the two
γ  subunits that have been characterized to date, namely
γ 1 in the homologous skeletal myotube system described
here and γ 2 described above in heterologous BHK cells
[17], appear to be inhibitory. In each case, the presence
of γ  results in fewer Ca2+ channels available for activa-
tion.
Absence of changes in the EC coupling voltage sensor of γ 1 
nullmyotubes
The impact of the γ 1 null mutation on myotube EC cou-
pling was inferred from intramembrane charge move-
ments, the bulk of which have been shown to originate
from the DHPR voltage sensor [27,28]. Additionally, we
measured Ca2+ transients evoked by voltage (i.e., by the
movement of the voltage sensor) and compared these
two sets of data. To measure DHPR charge movements
and to separate these charge movements from those pro-
duced by other voltage-gated channels, a) ionic currents
were blocked; b) the linear component of the cell capaci-
ty was subtracted using a P/4 procedure and by analog
compensation; and c) we used a pulse protocol that elim-
inated the immobilization-sensitive charge movements
from voltage-gated Na+ channels and presumably also
from T-type Ca2+ channels. Previous studies in dysgenic
(α 1S null) myotubes transfected with α 1S showed that the
pulse protocol and the internal and external solutions
used here (see Materials and Methods) detected charge
movements of a magnitude 5 to 8 fold larger than those
present in non-transfected dysgenic myotubes [28].
Thus we are confident that the technique adequately
measures intramembrane charge movements in DHPR
voltage sensors present in the plasma membrane. Fig. 4A
shows "gating-type" currents produced by charge move-
ments in response to 3 of 14 step voltages delivered to
each cell (-40, +10, and +70 mV). Charge movements did
not occur at -40 mV in any of the cell types. Traces at +10
mV and +70 mV show a transient current at the onset of
the voltage step, the ON charge, and an equal inverted
current at the end of the voltage step, the OFF charge.
The voltage-dependence of the OFF charge estimated by
integration is shown in Fig. 4B. The OFF transient was
usually less contaminated by ionic current than the ON
transient, and for that reason it provides a better esti-
mate of the total DHPR charge. The main contaminant of
the ON transient was a non-linear outward current, pre-
sumably a K+ channel that was not always completely
blocked by the pipette solution. The OFF charge in-
creased in a sigmoidal fashion and saturated at poten-
tials more positive than +60 mV in all cases. These data
were adequately fit by a Boltzmann equation shown by
the lines. We found that the fitted maximum charge
(Qmax) expressed by the 3 cell types was ∼  5 fC/pF, in
agreement with previous determinations in normal myo-
tubes [29]. Furthermore, Boltzmann parameters deter-
mined for each cell and then averaged were not
significantly different in any of two-by-two comparisons
between control, γ 1 het or γ 1 null cells (Table 1). In sum-
mary, the magnitude of intramembrane charge move-
ments and its voltage dependence were unaltered byBMC Physiology (2001) 1:8 http://www.biomedcentral.com/1472-6793/1/8
partial or complete removal of the γ 1 subunit. Further-
more, in agreement with previous data [29], no addition-
al charges moved when pulses were delivered from a
holding potential of -120 mV (data not shown). Thus,
failure to detect changes in the charge vs. voltage charac-
teristics of γ 1 null myotubes compared to controls cannot
be explained by charge movements in the γ 1 null myo-
tubes occurring at potentials more negative than the cho-
sen -80 mV holding potential.
Absence of alterations in the voltage dependence of
charge movement in the γ 1 null cells should also be re-
flected in the voltage-dependence of Ca2+ transients.
Changes in intracellular Ca2+ were measured using con-
focal line-scan imaging of fluo-4 fluorescence. Fig. 5A
shows a line-scan image of a Ca2+ transient stimulated
by a 50 ms depolarization to +90 mV from a holding po-
tential of -40 mV in each cell type. The scan direction was
perpendicular to the long axis of the myotube in a region
selected on the basis of a low resting fluorescence and a
high stimulated fluorescence (red/yellow color). The two
traces on top of each image correspond to the time
course of the fluo-4 fluorescence averaged across the en-
tire line-scan at -10 mV, which is close to the threshold,
and at +90 mV, which produced the maximum Ca2+
transient. Increase in cytosolic Ca2+ started at the onset
of the depolarization and peaked ∼  100 ms later in the
three cell types. For all cells, the peak fluorescence
change for the depolarization to +90 mV was >3 ∆ F/Fo
units, which is equivalent to >4 times the resting fluores-
cence. The relatively long recovery time following the de-
polarization is due to the low Ca2+ buffering power of the
internal recording solution and is in agreement with pre-
vious studies [27,30]. The voltage dependence of ∆ F/Fo
Figure 4
Voltage dependence of intramembrane charge movements in γ 1 knockout myotubes. A) Whole-cell current pro-
duced by charge movements in response to 3 of 14 25-ms voltage steps delivered to the same cell. The voltage steps shown
are to -40 mV, +10 mV, and +70 mV. The cell capacitance was 241 pF for the control, 292 pF for the γ 1 het and 253 pF for the
γ 1 null cell. B) Voltage dependence of charge movement obtained by integration of the OFF transient current for 8 control, 4
γ 1 het, and 8 γ 1 null cells. The curves correspond to a Boltzmann fit of the population mean with the following parameters.
Qmax = 5.2 fC/pF, V1/2 = 13.2 mV and k = 9 mV for control cells. Qmax = 4.9 fC/pF; V1/2 = 15 mV and k = 14.5 mV for γ 1 het
cells. Qmax = 5.4 fC/pF, V1/2 = 19.6 mV and k = 16 mV for γ 1 null cells.
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measured at the peak of the transient is shown in Fig. 5B.
All curves had the same profile which consisted of a
threshold for peak Ca2+ release at -10 mV, an increase in
peak Ca2+ with pulse potential from -10 mV to +30 mV
and a plateau at more positive potentials. Furthermore,
two-by-two comparisons of Boltzmann parameters fitted
to each cell did not reveal statistically significant differ-
ences (see Table 1). In summary, the voltage-dependence
of Ca2+ transients and the maximum cytosolic Ca2+ con-
centration during the transient were not significantly af-
fected by partial or total absence of the γ 1 subunit.
However, we cannot rule out changes in the rate of SR
Ca2+ release since this measurement requires an entirely
different internal solution [31]. A recent report indicates
that the SR Ca2+ release rate is slightly higher in γ 1 null
myotubes [32].
Involvement of DHPR subunits in voltage sensing and EC 
coupling
The α 1S pore subunit of the skeletal DHPR is the main
determinant of charge movements and EC coupling
[4,27,28]. However, other subunits of the DHPR are crit-
ical modulators of both functions. In heterologous ex-
pression systems, the α 2-δ  subunit was shown to affect
the rate of Ca2+ current inactivation and charge move-
ment immobilization [33]. Studies investigating the role
of the β  subunit on charge movement vary with the ex-
pression system used. In amphibian oocytes, β  subunits
increase the coupling between charge movements and
Figure 5
Voltage-dependence of Ca2+ transients in γ 1 knockout and normal myotubes. A) Confocal line-scan images of fluo-
4 fluorescence in response to a 50 ms step to +90 mV from a holding potential of -40 mV. Hot colors represent high fluores-
cence (yellow>red). The pulse was delivered 100 ms after the start of the line-scan as indicated at the bottom of the figure.
Images have a horizontal dimension of 2.05 seconds in all cases. The vertical dimension was 15, 28, and 24 microns for the con-
trol, γ 1 het, and γ 1 null cells, respectively. The two curves on top of the image show the time course of the fluorescence inten-
sity at -10 mV and +90 mV. 1 ∆ F/Fo unit corresponds to a doubling of the cell resting fluorescence. B) Voltage-dependence of
the peak ∆ F/Fo for 6 control, 4 γ 1 het, and 6 γ 1 null cells. The curves correspond to a Boltzmann fit of the population mean
with the following parameters. ∆ F/Fomax = 3.8, V1/2 = 10 mV, k = 9.4 mV for control cells. ∆ F/Fomax = 3.6, V1/2 = 10.8 mV; k =
10.9 mV for γ 1 het cells. ∆ F/Fomax = 3.7, V1/2 = 4.5 mV; k = 10 mV for γ 1 null cells.
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channel opening [34,35]. We have shown in skeletal
muscle cells lacking the β 1 subunit that reintroduction of
variants of β 1 has little effect on either charge movement
or the kinetics of activation of the expressed Ca2+ current
[15]. However, the carboxyl terminus of β 1a is an impor-
tant determinant of the efficiency of the coupling be-
tween charge movement and Ca2+ release [15]. In
contrast to these results, earlier studies in which similar
β  subunits were co-expressed with α 1 subunits in oocytes
indicated β  subunits had major effects on Ca2+ current
density and gating kinetics [36,37]. While the reason for
these discrepancies is unknown, they highlight the fact
that in skeletal muscle, the gating characteristics of the
L-type Ca2+ channel might be controlled by interactions
beyond those taking place among subunits of the DHPR.
For example, a region of RyR1 has been shown to be es-
sential for L-type Ca2+ current expression [38]. Such in-
teraction is critical for skeletal DHPR function and is
unlikely to occur in heterologous expression systems.
Conclusions
The ability of the γ 1 subunit to selectively modulate the
pore function of the DHPR without modulation of charge
movements or the voltage dependence of Ca2+ transients
is unique, especially since other DHPR subunits partici-
pate in both functions. In all likelihood, the charge move-
ment protocol failed to detect gating currents
responsible for opening the Ca2+ channel, which are
quite small and are only resolved for depolarizations
>200 ms [39] compared to the 25 ms used here (Fig. 4).
A possible shift in the voltage-dependence of these
charges recruited by long depolarizations would be con-
sistent with the shift in Ca2+ current inactivation and re-
mains to be resolved in γ 1 null myotubes. However, the
protocol accurately measures the immobilization-resist-
ant charge movements that are known to be required for
skeletal-type EC coupling [31,40]. Therefore, the γ 1 sub-
unit is unlikely to play a critical role in the activation of
SR Ca2+ release, in agreement with a recent report [32].
However, shifts in voltage dependence below the limit of
resolution (see Materials and Methods) and effects on
charge movement and Ca2+ release inactivation cannot
be completely ruled out. The γ 1 knockout mice provide a
unique resource to understand the function of this pro-
tein in myotubes in molecular detail.
Materials and Methods
Gene targeting
Bacteriophage clones containing portions of the γ 1 gene
were isolated from a mouse 129Sv genomic library
(Stratagene, La Jolla, CA #946305). To inactivate the γ 1
gene, a 4.4 kb BamHI/XhoI fragment upstream of exon
1 was subcloned into a multiple cloning site 5' of the neo
and Herpes virus TK gene that was in pBluescript (Strat-
agene). A second 2.6 kb EcoRI/BamHI fragment 3' of
exon 4 of the γ 1 gene was cloned into a site between the
neo and TK genes (Fig. 1Aii). Thus, the targeting vector
contains 4.4 kb of identity with the native γ 1 gene 5', and
2.6 kb of identity 3' of the neo cassette, respectively. The
targeting vector also contains the HSV TK gene to allow
for negative selection of non-recombinants. A unique
BamHI restriction site was used to linearize the plasmid
prior to its introduction into mouse ES cells by electropo-
ration. The γ 1 gene contains 4 exons, and correct target-
ing results in the deletion of all 4 exons, which will
inactivate the gene (Fig. 1Aiii). Probe 2 was used for
identification of targeted clones [41]. 5 µg of the targeting
vector was electroporated into 5 ×  106 AB1 ES cells. G418
and FIAU (1-(2'-deoxy-2'-fluoro-γ -D-arabinofuranosyl)-
5-iodouracil) resistant clones were analyzed by Southern
blotting after digestion with either EcoRI and hybridiza-
tion to probe 1 or digestion with HindIII and hybridiza-
tion to probe 2 (Fig. 1). Of three clones targeted on the 5'
end, two also were targeted on the 3' end. These were ex-
panded and used to produce germline chimeras. Mice
homozygous for the targeted allele were viable, with no
apparent abnormalities. Mice heterozygous and ho-
mozygous for the targeted mutation are referred to as γ 1
het and γ 1 null, respectively.
Western blots
Total microsomes were prepared from the forelimb and
hind limb muscles of control, γ 1 het, and γ 1 null adult
mice as previously described [42]. Total microsomes
were washed twice with 0.6 M KCl buffer and 100 µg of
total membrane protein was applied to a 5-15% SDS
polyacrylamide gel. Proteins were transferred to PVDF
membranes and analyzed with either anti-α 1S mAb IIC12
antibody [43], or anti-α 2-δ  protein G-purified guinea pig
antibody #1 [13], or anti-β 1a affinity-purified sheep #6
antibody [44], or with anti-γ 1 affinity-purified guinea pig
#16 antibody and the appropriate secondary antibodies
[11]. The subunits were visualized using SuperSignal
ECL reagent (Pierce, Rockford, IL). The images were
captured on a Chemi-Imager (Alpha Innotech, San Lean-
dro, CA) set to a level just below saturation.
Primary cultures of mouse myotubes
Primary cultures were prepared from hind limbs of day
18 embryos (E18) as described previously [45]. Dissected
muscles were incubated for 9 min at 37°C in Ca2+/Mg2+-
free Hanks balanced salt solution (in mM: 136.9 NaCl, 3
KCl, 0.44 KH2PO4, 0.34 NaHPO4, 4.2 NaHCO3, 5.5 glu-
cose, pH 7.2) containing 0.25% (w/v) trypsin and 0.05 %
(w/v) pancreatin (Sigma, St. Louis, MO). Mononucleat-
ed cells were resuspended in plating medium containing
78% Dulbecco's modified Eagle's medium (DMEM) with
low glucose (Life Technologies, Rockville, MD), 10 %
horse serum (HS, Sigma, St. Louis, MO), 10 % fetal bo-
vine serum (FBS, Sigma, St. Louis, MO), 2% chicken em-BMC Physiology (2001) 1:8 http://www.biomedcentral.com/1472-6793/1/8
bryo extract (CEE, Life Technologies, Rockville, MD)
and plated on plastic culture dishes coated with gelatin at
a density of ∼  1 ×  104 cells per dish. Cultures were grown
at 37°C in 8 % CO2. After the fusion of myoblasts (∼  7
days), the medium was replaced with a FBS-free medium
(88.75 % DMEM, 10 % HS, 1.25% CEE) and cells were in-
cubated in 5% CO2. All media contained 0.1 % v/v peni-
cillin and streptomycin (Sigma, St. Louis, MO). All
measurements were made when the cells had been in
culture for 7-10 days. During this time the maximal cur-
rent density did not change [45].
Electrophysiological measurements
Whole-cell recordings were performed as described pre-
viously [29] using an Axopatch 200B amplifier (Axon In-
struments, Foster City, CA). Linear capacity and leak
currents were compensated with the circuit provided by
the manufacturer. Series resistance, Rs, was compensat-
ed up to the point of amplifier oscillation with the Axo-
patch circuit. Considering all cells in the present study,
the linear capacitance (mean ± SE) of control, γ 1 null, and
γ 1 het myotubes was 256 ± 25 pF (38 cells), 246 ± 16 pF
(34 cells) and 223 ± 24 (23 cells), respectively. Rs of the
same cells before analog compensation was 7 ± 0.5 MΩ ,
7.2 ± 0.4 MΩ , and 6.3 ± 0.5 MΩ , respectively. Following
compensation, the effective Rs was <2 MΩ  in all cases
measured, although this was not measured systematical-
ly. Considering a mean cell capacitance of 240 pF, a typ-
ical maximum current density of 5 to 10 pA/pF (see Fig.
3B), and Rs (effective)<2 MΩ , the voltage error was <2.4
to <4.8 mV. All experiments were performed at room
temperature. Patch pipettes had an open tip resistance of
1-2 MΩ  when filled with the pipette solution. Ca2+ cur-
rents were measured from a holding potential of -40 mV.
Test pulses of 500 ms in 5 mV increments ranged from -
40 mV to +60 mV. Ca2+ conductance vs. voltage curves
were obtained by extrapolation of the Ca2+ current to the
reversal potential of the cell. To measure inactivation,
cells were held at -80 mV, then stepped to a series of de-
polarizing (pre-pulse) voltages, from -70 mV to +70 mV
in 10 mV increments, for 2.5 seconds to promote inacti-
vation, then stepped to -50 mV for 100 ms to close non-
inactivated channels, then stepped for 200 ms to the test
potential of +20 mV to measure Ca2+ currents, then
stepped to the -80 mV holding potential for 5 seconds to
permit recovery from inactivation. Charge movement
was measured using a protocol that eliminated immobi-
lization-sensitive components [15,28,29]. Voltage was
stepped from a holding potential of -80 mV to -35 mV for
750 ms, then to -50 mV for 5 ms, then to test potential for
25 ms, then to -50 mV for 30 ms and finally to the -80
mV holding potential. Subtraction of the linear compo-
nent was assisted by a P/4 procedure following the pulse
paradigm listed above. P/4 pulses were separated by 500
ms and had a duration of 25 ms. Previous studies showed
this choice of pulse protocol and internal and external
solutions resulted in nifedipine-sensitive charge move-
ments of a magnitude ∼  5 fold larger than those detected
in dysgenic myotubes lacking α 1S [29].
Solutions
The external solution in all cases was (in mM) 130 TEA
methanesulfonate, 10 CaCl2, 1 MgCl2, 10 HEPES titrated
with TEA(OH) to pH 7.4. For Ca2+ transients and Ca2+
currents, the pipette solution was (in mM) 140 Ca2+-As-
partate, 5 MgCl2, 0.1 EGTA (Ca2+ transients) or 5 mM
EGTA (Ca2+ currents), and 10 MOPS-CsOH pH 7.2. For
charge movements, the pipette solution was (in mM) 120
NMG (N-methyl glucamine)-Glutamate, 10 HEPES-
NMG, 10 EGTA-NMG pH 7.3. For charge movements,
the external solution was supplemented with 0.5 mM
CdCl2 and 0.5 mM LaCl3 to block the Ca2+ current and
0.05 mM TTX to block residual Na+ current.
Ca2+ transient measurements
Ca2+ transients were measured using a confocal micro-
scope in line-scan mode as described previously
[46,47,48]. Cells were loaded with 4 mM fluo-4 (fluo-4
acetoxymethyl (AM) ester, Molecular Probes, Eugene,
OR) for 20 to 40 min at room temperature. Stocks of
fluo-4 (1 mg/ml) were made in DMSO and stored frozen.
All experiments were performed at room temperature.
Cells were viewed with an inverted Olympus microscope
with a 20X objective (N.A. = 0.4) and a Fluoview confo-
cal attachment (Olympus, Melville, NY). The 488 nm
spectrum line necessary for fluo-4 excitation was provid-
ed by a 5 mW argon laser attenuated to 20% with neutral
density filters. The fluorescence intensity, F, was calcu-
lated by densitometric scanning of line-scan images and
was averaged over the entire width of the cell. The back-
ground fluorescence intensity (Fo) was averaged in the
same manner from areas of the same image prior to the
voltage pulse. The fluorescence unit ∆ F/Fo corresponds
to (F-Fo)/Fo. The limit of fluorescence detection, based
on microscope settings and the average resting fluo-4
fluorescence, was ∼  0.1 ∆ F/Fo units. That is, we could de-
tect a ∼  10% change above the cell resting fluorescence.
Using a pseudo-ratiometric equation for estimating the
cytosolic free Ca2+ [48] and assuming a resting free Ca2+
of 100 nM [48], the nominal limit of resolution of free
Ca2+ change was ∼  200 nM.
Data and error analysis
For each cell, or for the population average, the voltage
dependence of charge movements (Q), Ca2+ conductance
(G), and peak intracellular Ca2+ (∆ F/Fo) were fitted ac-
cording to a Boltzmann equation A = Amax/(1+exp(-(V-
V1/2)/k)) where Amax was either Qmax, Gmax or ∆ F/Fo-
max; V1/2 is the potential at which A = Amax/2; and k is
the slope factor. For a fit of steady-state inactivation, theBMC Physiology (2001) 1:8 http://www.biomedcentral.com/1472-6793/1/8
term (V-V1/2) in the equation above was replaced by (V1/
2-V). Ca2+ conductance for each cell was computed from
the extrapolated reversal potential and the maximal Ca2+
current at each voltage. In all figures, the symbols and er-
ror bars correspond to the population mean ± 1 SEM. The
curves correspond to a Boltzmann fit of the mean. In ad-
dition to Student t-tests reported in Table 1, one-way
ANOVA tests were conducted among the 11 sets of Boltz-
mann parameters of control, γ 1 het and γ 1 null cells of Ta-
ble 1. The null hypothesis (equality of means) was not
rejected at a level of significance p<0.05 except in the
two cases also identified by t-tests, namely Gmax and V1/
2 inactivation. An F-test, which formally tests for the dif-
ference between the variances of independent popula-
tions, was used to determine which of the fitted
Boltzmann parameters (Amax, V1/2, k) had the largest
variance, and thus the largest experimental error. The
ranking order in variance error was V1/2>Amax>k. Fur-
thermore, the error in V1/2 was the largest for the fluo-
rescence measurement and the smallest for the
conductance measurement. This result was expected
since the size of the voltage step used in the V1/2 determi-
nation was 5 mV for conductance, 10 mV for charge
movements, and 20 mV for fluorescence. The number of
voltage steps in fluorescence measurements was kept to
a minimum to avoid rundown of the Ca2+ transient due
to photobleaching. The limit of resolution of V1/2, the pa-
rameter with the largest error, was estimated with a z-
test which formally tests for the difference between the
mean of a population and a hypothetical mean. We de-
termined the smallest difference between a experimental
and a hypothesized V1/2 resolvable at a level of statistical
confidence p<0.05. In the calculations, we used the data
with the largest V1/2 variance for each measurement
(conductance, charge movement and fluorescence). Al-
so, we assumed a hypothetical S.D. equal to the experi-
mental S.D. The estimated limits of statistical resolution
were ∼  3.9 mV for conductance, ∼  6.5 mV for charge
movements, and ∼  8.5 mV for fluorescence measure-
ments. Thus, a difference in population mean V1/2 of less
than the indicated limit would not be statistically signif-
icant, given the variance and the number of determina-
tions of the present study. Statistical analyses were
performed with Analyse-it software (Leeds, UK)
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